BMS 6077 (Metaglip 2.5 mg / 500 mg)
Generic Name: glipizide/metformin
Pill imprint BMS 6077 has been identified as Metaglip 2.5 mg / 500 mg.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 6077 (Metaglip 2.5 mg / 500 mg)
- Generic Name:
- 2.5 mg / 500 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|54868-5399||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Metaglip (glipizide / metformin)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...